TWiV 1006: Clinical update with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In his weekly clinical update, Dr. Griffin discusses immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age, influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults, COVID-19 surveillance after expiration of the public health emergency declaration, provisional mortality data, targeted vaccine messaging to promote COVID-19 vaccines for children and youth, vaccines and related biological products advisory committee meeting June 15, 2023 announcement, how to overhaul the CDC, impact of SARS-CoV-2 variants on inpatient clinical outcome, prevalence of post-coronavirus disease condition 12 weeks after Omicron infection compared with negative controls and association with vaccination status, gut bacteria cocktail helps long COVID, and gut microbiota‐derived symbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Immunogenicity and tolerability of a bivalent norovirus vaccine in children (HVI)
- Influenza hemagglutinin stem nanoparticle vaccine induces neutralizing antibodies in healthy adults (STM)
- COVID-19 surveillance after expiration of the public health emergency declaration (CDC)
- Provisional mortality data (CDC)
- Targeted messaging to promote COVID-19 vaccines for children and youth (Pediatrics)
- Vaccines and biological products advisory committee meeting announcement (FDA)
- How to overhaul the C.D.C (NYTIMES)
- Impact of SARS-CoV-2 variants on inpatient clinical outcome (CID)
- Prevalence of post-COVID19 condition 12 weeks after Omicron infection and vaccination status (CID)
- Gut bacteria cocktail helps long COVID (MedPage)
- Gut microbiota‐derived synbiotic formula as a therapy for COVID‐19 (NIH)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1006
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]